Anthropic establishes a wet lab and launches verification program for life sciences research.

Anthropic CEO Dario Amodei has said his focus on neglected diseases is partly personal: his father died from an illness only a few years before researchers discovered an effective treatment.
Anthropic’s life-sciences chief, Eric Kauderer-Abrams, described physical laboratory experimentation as the ultimate validation of biological research, underscoring why the company is moving beyond purely computational work.
Bloom’s evaluation process is organized into four stages—Understanding, Ideation, Rollout and Judgment—and its technical report applies the framework across 16 frontier models and four behavioral categories.
Bloom’s code is released under the MIT license, allowing broad reuse subject to the license’s terms, while the framework is intended to provide reproducible testing rather than a formal safety certification.
Anthropic says the Life Sciences Verification Program was developed in partnership with the U.S. government; it is one of two trusted-access routes for Mythos 5.1, alongside the Cyber Verification Program, and its first participants have already been enrolled.
Anthropic is quietly expanding into physical biology with a newly disclosed Bay Area wet lab, part of a broader push to apply its AI models to drug discovery and neglected diseases. Business Today reports the lab will conduct high-throughput experiments and synthesize biological data. The company has also launched a gated Life Sciences Verification Program giving vetted researchers access to biology-focused AI models for drug discovery and clinical development.
The moves mark Anthropic's shift from purely computational biology work into hands-on laboratory experimentation. NDTV Profit notes the company aims to accelerate AI capabilities in life sciences and medicine. The company has recruited biomedical expertise, acquired Coefficient Bio, and launched Claude Science to support these efforts.
Eric Kauderer-Abrams, Anthropic's life-sciences chief, says physical laboratory experimentation is the ultimate validation of biological research. Computational models alone cannot fully test whether biological theories actually work in real cells and tissues. This gap drove Anthropic to build a wet lab where researchers can test AI-generated hypotheses directly. Firstpost reports the lab represents Anthropic's expansion into physical biology research after years of warning about AI risks.
CEO Dario Amodei's focus on neglected diseases stems partly from personal experience—his father died from an illness only years before researchers discovered an effective treatment. That tragedy underscores why Anthropic is investing now in diseases that pharmaceutical companies often ignore due to limited profit potential.
Anthropic launched an invite-only Life Sciences Verification Program to give vetted life-sciences organizations controlled access to specialized AI models including Mythos 5.1, Opus 5, and Sonnet 5. Deccan Chronicle reports applicants undergo reviews of credentials, security practices, and ethical oversight. Approved teams may receive grants for standard or higher-risk research projects.
The program operates as one of two trusted-access routes for Mythos 5.1, alongside a separate Cyber Verification Program. Biology-related restrictions are relaxed within the Life Sciences program, but safeguards remain for other sensitive areas like cybersecurity. The first participants have already been enrolled, developed with U.S. government partnership.
Anthropic released Bloom, an open-source framework for evaluating how frontier AI models behave in complex scenarios. The framework organizes evaluation into four stages: Understanding, Ideation, Rollout, and Judgment. Newsbytes notes the work explores the role of AI in medicine and biological research. Bloom's technical report applies the framework across 16 frontier models and four behavioral categories to test safety and reliability.
The code is released under the MIT license, allowing broad reuse. Anthropic also released Petri, an auditing tool for examining how AI risks interact with each other. Both tools aim to provide reproducible testing rather than formal safety certification. Together they expand Anthropic's evaluation capabilities beyond traditional benchmarks.
Publishers
24
Articles
113
Reach
137